Introduction
============

Obesity is a major public health challenge in the United States and around the world.[@ref1] In 2013-14, more than two thirds of Americans were classified as overweight (defined as body mass index (BMI) of 25-29.9) or obese (BMI of ≥30).[@ref2] BMI is known as a reasonably good measure of general adiposity,[@ref3] and many epidemiologic studies have provided evidence showing that obesity, assessed by BMI, is a significant risk factor for increased risk of many chronic diseases as well as mortality.[@ref4] [@ref5] [@ref6] However, the shape of the association between BMI and mortality has been a topic of considerable discussion, as epidemiologic studies have found various types of J shaped, U shaped, and linear relations between BMI and mortality.[@ref7] For instance, overweight was associated with increased mortality in some studies,[@ref8] but in others the lowest mortality was observed among overweight people and mortality tended to increase with lower BMI, even after smoking (residual confounding) and pre-existing disease (reverse causation) had been accounted for.[@ref9] [@ref10] This pattern has come to be known as the "obesity paradox."[@ref11] Given the existing and rising number of overweight and obese adults in the US, these divergent findings cause a great deal of confusion among researchers, policy makers, and the general public.

One important but underexplored methodological limitation in the obesity research is that BMI is an imperfect measure of adiposity.[@ref12] [@ref13] [@ref14] [@ref15] Although BMI indicates overweight relative to height, it does not discriminate between fat mass and lean body mass.[@ref16] [@ref17] [@ref18] Body composition is highly variable among individuals with the same BMI. This is particularly important because fat mass and lean body mass may act differently on health outcomes including mortality. Excess fat mass has shown to be detrimental for health,[@ref19] whereas growing evidence suggests that skeletal muscle, which accounts for most of lean body mass, may be beneficial for health.[@ref20] [@ref21] Therefore, understanding the different contributions of lean body mass and fat mass to BMI may provide new insights on the obesity paradox and deliver important clinical and public health messages about healthy body composition beyond BMI. However, direct measurement of lean body mass is particularly difficult in large epidemiologic studies because it requires expensive and sophisticated technologies such as dual energy *x* ray absorptiometry or imaging technologies. Therefore, little is known about the influence of body composition, particularly lean body mass, on mortality. A limited number of studies have used less accurate surrogate measures (for example, arm circumference,[@ref22] [@ref23] total body potassium,[@ref24] skinfold thickness,[@ref25] and bioelectrical impedance[@ref26]) or direct measures to estimate body composition,[@ref27] [@ref28] [@ref29] [@ref30] [@ref31] [@ref32] [@ref33] but these studies had relatively small sample size, short period of follow-up, restricted study population (for example, older people), and/or potential biases (for example, confounding and reverse causation). Moreover, the association of lean body mass and fat mass with cause specific mortality is largely unknown.

Therefore, we used validated anthropometric prediction equations to estimate body composition and examine the association of predicted lean body mass, fat mass, and BMI with all cause and cause specific mortality in a large prospective US cohort study of men. The application of validated equations in a large cohort allowed us to estimate lean body mass and fat mass and examine the independent roles of two different body components in relation to mortality, accounting for potential biases.

Methods
=======

Study population
----------------

The Health Professionals Follow-up Study started in 1986, when 51 529 male health professionals aged 40-75 years were enrolled. Participants were mailed questionnaires at baseline and every two years thereafter to collect updated demographic, lifestyle, and medical information. For the analysis, we included participants who had information on age, race, height, weight, and waist circumference, which we needed to create predicted lean body mass and fat mass (n=40 226). We excluded participants previously diagnosed as having cancer or cardiovascular diseases (n=1595) and those with BMI below 12.5 or above 60 (n=625) at baseline. The final sample size was 38 006 men.

Exposure assessments
--------------------

Derivation and validation of the predicted lean body mass and fat mass have been described in detail previously.[@ref34] Briefly, we used a large US representative sample of 7531 men who had measured dual energy *x* ray absorptiometry from the National Health and Nutrition Examination Survey (NHANES). With lean body mass and fat mass measured by dual energy *x* ray absorptiometry each as a dependent variable, we did a linear regression using age, race, height, weight, and waist circumference as independent predictors. We then validated the developed equations in an independent validation group of 2292 men and further by using obesity related biomarkers (triglycerides, total cholesterol, high density and low density lipoprotein cholesterol, glucose, insulin, and C reactive protein). The anthropometric prediction equations (supplementary table A) had high predictive ability for lean body mass (R^2^=0.91, standard error of estimate 2.55 kg) and fat mass (R^2^=0.90, standard error of estimate 2.60 kg). In the independent validation group, the actual and predicted lean body mass and fat mass showed robustly high agreement with no evidence of bias. Moreover, the developed equations performed well across different subgroups of the validation group (that is, age, BMI, race, smoking status, and disease status), and predicted fat mass and dual energy *x* ray absorptiometry measured fat mass showed similar correlations with obesity related biomarkers (Pearson correlations for predicted and measured fat mass, respectively, were 0.33 *v* 0.34 for triglycerides, 0.21 *v* 0.21 for total cholesterol, −0.21 *v* −0.22 for high density lipoprotein cholesterol, 0.19 *v* 0.20 for low density lipoprotein cholesterol, 0.25 *v* 0.22 for glucose, 0.51 *v* 0.54 for insulin, and 0.31 *v* 0.32 for C reactive protein).[@ref34] In an additional validation using the same validation group, dual energy *x* ray absorptiometry measured values and predicted values showed consistently high agreement with similar errors across the range of lean body mass and fat mass. Scatter plots of the difference between measured and predicted values against measured values showed no strong non-linear pattern (supplementary figures A and B; supplementary tables B and C). For a sensitivity analysis, we also used different prediction equations that include additional polynomial terms of anthropometric measures (supplementary table A). These equations had similar R^2^ and standard error of estimates but slightly improved fit in the extreme range of lean body mass and fat mass (supplementary figures A and B; supplementary tables B and C). Using the equations, we calculated predicted lean body mass and fat mass for each cohort member on the basis of their age, race, height, weight, and waist circumference. Predicted lean body mass and fat mass were available in 1987, 1996, and 2008.

We collected information on height at enrollment in 1986 and on weight from biennial questionnaires. Distinct from the biennial questionnaire, participants were asked to measure and report their waist circumferences to the nearest quarter inch using provided tape measures and following the same instructions in 1987, 1996, and 2008. Non-responders received follow-up mailings to increase the response rate. In our validation study, the correlation between self reported and technician measured weight and waist circumference were 0.97 and 0.95, respectively.[@ref35]

Ascertainment of outcomes
-------------------------

Deaths were identified by reports from the next of kin or postal authorities or by searching the National Death Index. More than 98% of deaths were ascertained from the follow-up. Cause of death was determined by physicians reviewing medical records and death certificates. ICD-8 (international classification of diseases, 8th revision) codes were used to classify deaths from cardiovascular disease (codes 390-459, 795), cancer (codes 140-239), respiratory disease (codes 460-519), and other causes.

Ascertainment of covariates
---------------------------

Detailed information on age, race, smoking, and physical activity were collected in 1986 and updated every two years from biennial questionnaires. Family history of cardiovascular disease and cancer were assessed periodically. Dietary information was collected via validated food frequency questionnaires every four years. The Alternate Healthy Eating Index was calculated as an overall measure of diet quality.[@ref36]

Statistical analyses
--------------------

We calculated a Spearman correlation between predicted lean body mass and fat mass. We calculated person time of follow-up from the age at which the baseline predicted lean body mass and fat mass were available until the age at death or the end of study (January 2012), whichever came first. We used Cox proportional hazards models to estimate hazard ratios and 95% confidence intervals. We stratified the analysis by age in months and calendar year of the questionnaire cycle.

We categorized predicted fat mass and lean body mass into fifths on the basis of the distribution of exposures. We used predefined cut points for BMI (\<18.5, 18.5-20.4, 20.5-22.4, 22.5-24.9, 25-27.4, 27.5-29.9, 30-34.9, and ≥35). For the main analysis, we used predicted fat mass, lean body mass, and BMI measured at baseline to minimize the effect of underlying diseases on mortality. To account for variation in body size, we adjusted for height by including it as a continuous variable in the models with predicted fat mass. As lean body mass is largely determined by height, and thus highly correlated with it, we adjusted for residuals from the regression of predicted lean body mass on height to better capture lean body mass (mostly muscle mass) not related to height. In multivariable models, we adjusted for potential confounders including race, family history of cardiovascular disease, family history of cancer, smoking status, physical activity, total energy intake, alcohol consumption, and Alternate Healthy Eating Index. To examine the independent association of predicted lean body mass and fat mass with mortality, we further ran a multivariable model including both predicted lean body mass and fat mass. Height was adjusted using the same approach described above for lean body mass and fat mass in the mutually adjusted models. We tested for trend by treating the categorical predicted scores and BMI as continuous variables in the model after assigning a median value for each category.

We also used restricted cubic splines with five knots at the 5th, 35th, 50th, 65th, and 95th centiles to flexibly model the association of lean body mass, fat mass, and BMI with mortality. In the spline models, lean body mass and fat mass were mutually adjusted. We tested for potential non-linearity by using a likelihood ratio test comparing the model with only a linear term against the model with linear and cubic spline terms.[@ref37] [@ref38] [@ref39] As the associations of predicted lean body mass, fat mass, and BMI were approximately log linear below and above their medians, we additionally used a linear model to calculate hazard ratios per standard deviation increase in predicted lean body mass, fat mass, and BMI. Given our a priori hypothesis that people with low lean body mass in the lower BMI range cause the J or U shaped relation between BMI and mortality, we examined how the shape of BMI-mortality association changes after we excluded participants with low lean body mass (defined as those below the 2.5th, 5th, and 10th centiles of total participants). For a sensitivity analysis, we additionally examined the shape of BMI-mortality relation after excluding those with low fat mass, using the same criteria as for lean body mass.

To evaluate the latency between predicted lean body mass and fat mass and mortality, we did analyses using different lag times (approximately 0, 4+, 8+, and 12+ years). For each lagged analysis, the baseline was shifted to 1987, 1990, 1994, and 1998, respectively, and predicted lean body mass and fat mass were updated using three repeated measures accordingly. For example, for the no lag time analysis (simple updated), we used the most updated predicted lean body mass and fat mass that were closest to the time of death. For a lag time of 4+ years, we used predicted measures in 1987 for follow-up from 1990 to 2000 and predicted measures in 1996 for follow-up from 2000 to 2012. Similarly, for a lag time of 8+ years, we used predicted measures in 1987 for deaths in 1994-2004 and predicted measures in 1996 for deaths in 2004-12. Moreover, we did stratified analyses to explore whether the association of predicted lean body mass and fat mass with mortality varied across smoking status and age.

We did several sensitivity analyses with no adjustment for physical activity, exclusion of deaths that occurred early in the follow-up period (two years) and right censoring criteria for age (\>85 years), and inclusion of baseline illness. We also did analyses using different categories for predicted lean body mass, fat mass, and BMI (that is, fifths and tenths). Lastly, we tested the robustness of our findings by using other prediction equations with polynomial terms. All statistical tests were two sided, and we considered P\<0.05 to determine statistical significance. We used SAS 9.4 for all analyses.

Patient involvement
-------------------

No patients were involved in setting the research question or the outcome measures, nor were they involved in the design and implementation of the study. There are no plans to involve patients in dissemination.

Results
=======

Study participants
------------------

We included 38 006 men in the analyses. [Table 1](#tbl1){ref-type="table"} shows the baseline characteristics of participants according to BMI categories. The mean age was 54.4 years, and the mean BMI was 25.4. Predicted lean body mass increased with higher BMI. Predicted fat mass slightly deceased in the second category of BMI (18.5-20.4) and then increased with higher BMI. Moreover, men with lower BMI tended to have higher physical activity and Alternate Healthy Eating Index score, peaking in the third category of BMI (20.5-22.4). Although the number of men with underweight (BMI \<18.5) was small, they were taller and had lower physical activity and Alternate Healthy Eating Index score than men with normal weight (BMI 18.5-24.9). The Spearman correlation between predicted lean body mass and fat mass was 0.66 in men.

###### 

Age standardized baseline characteristics according to body mass index in men (Health Professionals Follow-up Study, 1987-2012). Values are mean (SD) unless stated otherwise

  Characteristics                              Body mass index                                                                                       
  -------------------------------------------- ----------------- ------------- ------------- ------------- ------------- ------------- ------------- --------------
  Person years                                 1839              15 337        92 790        254 122       243 335       95 023        52 320        8275
  Age, years[\*](#t1n1){ref-type="table-fn"}   55.5 (10.4)       54.0 (10.8)   53.8 (10.2)   54.0 (9.9)    54.5 (9.7)    54.9 (9.6)    55.1 (9.4)    55.5 (10.1)
  Height, cm                                   185.4 (12.7)      179.4 (7.8)   178.7 (6.2)   178.5 (6.4)   178.2 (6.5)   178.7 (6.8)   178.5 (7.1)   176.4 (10.0)
  Weight, kg                                   60.8 (8.2)        64.1 (5.7)    69.6 (5.1)    75.9 (5.8)    82.9 (6.4)    91.4 (7.3)    101.2 (9.0)   118.2 (13.9)
  Waist circumference, cm                      86.6 (12.4)       82.8 (5.3)    86.8 (5.1)    91.2 (5.6)    96.7 (6.1)    102.9 (6.8)   110.6 (7.9)   123.4 (11.4)
  Body mass index                              17.6 (0.8)        19.8 (0.5)    21.7 (0.5)    23.7 (0.7)    26.0 (0.7)    28.5 (0.7)    31.7 (1.3)    37.9 (3.6)
  Predicted fat mass, kg                       13.3 (5.0)        13.1 (2.5)    15.9 (2.4)    19.1 (2.6)    22.8 (2.9)    27.1 (3.3)    32.3 (4.1)    41.2 (6.5)
  Predicted lean body mass, kg                 40.4 (5.8)        47.5 (2.2)    50.6 (1.9)    53.9 (2.1)    57.4 (2.3)    61.2 (2.6)    65.9 (3.4)    75.2 (6.0)
  Total energy intake, kcal/day                2132 (610)        2023 (570)    2045 (599)    2002 (595)    1992 (609)    2002 (625)    2036 (639)    2089 (657)
  Alcohol consumption, g/day                   14.2 (18.7)       9.7 (14.2)    10.9 (14.3)   11.5 (14.7)   11.8 (15.4)   11.7 (15.5)   10.9 (16.1)   8.9 (15.1)
  AHEI score                                   51.4 (13.5)       54.1 (12.7)   54.3 (12.0)   53.8 (11.6)   52.4 (11.1)   51.5 (10.9)   50.7 (11.0)   49.3 (10.8)
  Physical activity, MET-h/week                21.4 (35.8)       22.6 (27.0)   24.2 (28.6)   22.3 (27.4)   19.4 (23.9)   16.8 (22.0)   14.4 (20.9)   11.7 (14.9)
  White (%)                                    98.4              99.2          99.5          99.3          99.2          98.8          98.7          99.4
  Family history of CVD (%)                    35.3              32.2          33.0          33.4          33.7          33.8          35.2          35.5
  Family history of cancer (%)                 17.6              16.8          17.2          16.8          17.5          16.9          16.8          15.4
  Smoking status (%):                                                                                                                                
   Never                                       47.4              56.5          56.0          50.5          45.8          44.1          42.3          41.1
   Past                                        34.0              32.3          35.2          42.2          46.0          47.5          50.0          50.6
   Current                                     18.6              11.2          8.9           7.3           8.2           8.4           7.8           8.3

AHEI=alternate healthy eating index; CVD=cardiovascular disease; MET=metabolic equivalent of task.

Value is not age adjusted.

All cause mortality
-------------------

During up to 25 years of follow-up (mean 21.4 years), we identified 12 356 deaths. [Table 2](#tbl2){ref-type="table"} shows the association of predicted fat mass and lean body mass with all cause mortality in men. A multivariable adjusted model showed a positive association between predicted fat mass and all cause mortality, whereas predicted lean body mass showed a U shaped association with all cause mortality. In a mutually adjusted model including both predicted fat mass and lean body mass, we consistently observed a strong positive association between predicted fat mass and all cause mortality. Compared with those in the lowest fifth of predicted fat mass, men in the highest fifth had a hazard ratio of 1.35 (95% confidence interval 1.26 to 1.46) for death from any cause. Moreover, predicted lean body mass showed a stronger U shaped association with all cause mortality in the mutually adjusted model. Compared with those in the lowest fifth of predicted lean body mass, men in the second to fourth fifths had 8-10% lower hazard of death from any cause.

###### 

Hazard ratio (95% CI) of all cause mortality according to predicted fat mass and lean body mass in men (Health Professionals Follow-up Study, 1987-2012)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  \                                                                 No of deaths   Incidence rate per 100 000 person years   Hazard ratio (95% CI)                         
  ----------------------------------------------------------------- -------------- ----------------------------------------- ----------------------- --------------------- ---------------------
  **Fifth of fat mass** [**§**](#t2n4){ref-type="table-fn"}                                                                                                                

  1 (lowest)                                                        1937           1265                                      1 (reference)           1 (reference)         1 (reference)

  2                                                                 2298           1504                                      1.09 (1.03 to 1.16)     1.06 (1.00 to 1.12)   1.08 (1.01 to 1.15)

  3                                                                 2297           1504                                      1.03 (0.97 to 1.09)     0.98 (0.92 to 1.04)   1.01 (0.94 to 1.07)

  4                                                                 2726           1789                                      1.23 (1.16 to 1.31)     1.13 (1.06 to 1.20)   1.16 (1.09 to 1.24)

  5 (highest)                                                       3098           2038                                      1.51 (1.42 to 1.60)     1.33 (1.25 to 1.41)   1.35 (1.26 to 1.46)

  P value for trend                                                                                                          \<0.001                 \<0.001               \<0.001

  **Fifth of lean body mass** [**§**](#t2n4){ref-type="table-fn"}                                                                                                          

  1 (lowest)                                                        2996           1969                                      1 (reference)           1 (reference)         1 (reference)

  2                                                                 2419           1585                                      0.93 (0.88 to 0.98)     0.93 (0.88 to 0.98)   0.92 (0.87 to 0.97)

  3                                                                 2324           1521                                      0.95 (0.90 to 1.01)     0.93 (0.88 to 0.98)   0.90 (0.85 to 0.96)

  4                                                                 2282           1494                                      1.03 (0.98 to 1.09)     1.00 (0.95 to 1.06)   0.92 (0.87 to 0.98)

  5 (highest)                                                       2335           1529                                      1.26 (1.20 to 1.34)     1.16 (1.10 to 1.23)   0.97 (0.91 to 1.04)

  P value for trend                                                 \-             \-                                        \<0.001                 \<0.001               0.49
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Adjusted for age.

Adjusted for age, race (white or non-white), family history of cardiovascular disease (yes or no), family history of cancer (yes or no), physical activity (\<3, 3-8.9, 9-17.9, 18-26.9, or \>27 MET-h/week), alcohol consumption (0, 0.1-4.9, 5-9.9, 10-14.9, or ≥15 g/day), total energy intake (fifths), smoking status (never, ever, 1-14, 15-24, or ≥25 cigarettes/day), and Alternate Healthy Eating Index (fifths).

Additionally, mutually adjusted for predicted fat mass and predicted lean body mass.

Derived from validated anthropometric prediction equations; height was adjusted by inclusion as continuous variable for fat mass and by regression out of variation due to height for lean body mass.

In [figure 1](#f1){ref-type="fig"}, we used restricted cubic splines to flexibly model and visualize the relation of predicted fat mass and lean body mass with all cause mortality in men. The risk of all cause mortality was relatively flat until around 21 kg of predicted fat mass and then started to increase rapidly afterwards (P for non-linearity \<0.001). The average BMI for men with 21 kg of predicted fat mass was 25. Above 21 kg, the hazard ratio per standard deviation higher predicted fat mass was 1.22 (1.18 to 1.26). Regarding the strong U shaped relation between predicted lean body mass and all cause mortality, the plot showed a substantial reduction of the risk within the lower range of predicted lean body mass, which reached the lowest risk around 56 kg and then increased thereafter (P for non-linearity \<0.001). Below 56 kg, the hazard ratio per standard deviation higher predicted lean body mass was 0.87 (0.82 to 0.92).

![Association of predicted body composition and body mass index (BMI)\* with all cause mortality in men. A: Fat mass and all cause mortality. B: Lean body mass and all cause mortality. C: BMI and all cause mortality. Hazard ratios are indicated by solid lines and 95% CIs by shaded areas. Reference point is lowest value for each of fat mass and lean body mass and 25 for BMI, with knots placed at 5th, 35th, 50th, 65th, and 95th centiles of each fat mass, lean body mass, and BMI distribution. All models were adjusted for cofounders in [table 2](#tbl2){ref-type="table"}. For graphs A and B, predicted fat mass and predicted lean body mass were mutually adjusted. \*Standard deviations: 5.7 kg for fat mass, 6.6 kg for lean body mass, and 3.1 for BMI; centiles (0, 2.5, 5, 10, 25, 50, 75, 90, and 100): 7, 13, 14, 15, 18, 21, 25, 29, and 66 kg for fat mass; 24, 48, 49, 51, 53, 56, 59, 63, and 103 kg for lean body mass; and 14.2, 20.5, 21.2, 22.0, 23.4, 25.1, 27.0, 29.3, and 62.0 for BMI](leed043414.f1){#f1}

When we used BMI alone, we observed a J shaped association between BMI and all cause mortality in men ([table 3](#tbl3){ref-type="table"} and [fig 1](#f1){ref-type="fig"}). We also examined the influence on BMI after excluding participants with low predicted lean body mass. When we excluded participants below the 2.5th centile of predicted lean body mass, the J shaped association between BMI and mortality disappeared. After exclusion of more participants with low predicted lean body mass (below 5th and 10th centiles), the BMI-mortality association became more linear and slightly stronger. However, the J shaped association still existed when we excluded those with low predicted fat mass (supplementary table D).

###### 

Hazard ratio (95% CI) of all cause mortality according to body mass index (BMI) in men (Health Professionals Follow-up Study, 1987-2012)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  \                   No of deaths   Incidence rate per\    Hazard ratio (95% CI)                                                                     
  BMI                                100 000 person years                                                                                             
  ------------------- -------------- ---------------------- ----------------------- --------------------- --------------------- --------------------- ---------------------
  \<18.5              53             2883                   1.74 (1.33 to 2.28)     1.65 (1.25 to 2.16)   NA                    NA                    NA

  18.5-20.4           269            1754                   1.16 (1.03 to 1.32)     1.09 (0.96 to 1.24)   0.95 (0.76 to 1.18)   0.95 (0.68 to 1.32)   0.79 (0.38 to 1.66)

  20.5-22.4           1358           1464                   1.01 (0.95 to 1.08)     1.03 (0.97 to 1.09)   1.01 (0.94 to 1.08)   0.99 (0.92 to 1.06)   0.93 (0.85 to 1.03)

  22.5-24.9           3740           1472                   1 (reference)           1 (reference)         1 (reference)         1 (reference)         1 (reference)

  25.0-27.4           3986           1638                   1.09 (1.04 to 1.14)     1.04 (0.99 to 1.09)   1.04 (1.00 to 1.09)   1.05 (1.00 to 1.10)   1.06 (1.01 to 1.11)

  27.5-29.9           1753           1845                   1.31 (1.24 to 1.39)     1.21 (1.14 to 1.28)   1.22 (1.15 to 1.29)   1.23 (1.16 to 1.30)   1.24 (1.17 to 1.31)

  30.0-34.9           1001           1913                   1.48 (1.38 to 1.59)     1.31 (1.22 to 1.41)   1.31 (1.22 to 1.41)   1.33 (1.24 to 1.43)   1.34 (1.25 to 1.44)

  ≥35.0               196            2368                   2.28 (1.98 to 2.64)     2.01 (1.74 to 2.33)   2.02 (1.75 to 2.34)   2.04 (1.76 to 2.36)   2.06 (1.78 to 2.38)

  P value for trend   \-             \-                     \<0.001                 \<0.001               \<0.001               \<0.001               \<0.001
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NA=not available (no cases available after exclusion).

Model 1 adjusted for age. Model 2 adjusted for age, race (white or non-white), family history of cardiovascular disease (yes or no), family history of cancer (yes or no), physical activity (\<3, 3-8.9, 9-17.9, 18-26.9, or \>27 MET-h/week), alcohol consumption (0, 0.1-4.9, 5-9.9, 10-14.9, or ≥15 g/day), total energy intake (fifths), smoking status (never, ever, 1-14, 15-24, or ≥25 cigarettes/day), and Alternate Healthy Eating Index (fifths). No of deaths/person years for each category of BMI: 53/1839, 269/15 337, 1358/92 790, 3740/254 122, 3986/243 335, 1753/95 023, 1001/52 320, and 196/8275.

Additionally, excluded participants with lean body mass below 2.5th centile. For exclusion analyses, height adjusted lean body mass was used after regression out of variation due to height. No of deaths/person years for each category of BMI: 0/26, 80/7196, 1147/85 194, 3695/252 987, 3980/243 212, 1751/94 960, 1000/52 311, and 196/8275.

Additionally, excluded participants with lean body mass below 5th centile. For exclusion analyses, height adjusted lean body mass was used after regression out of variation due to height. No of deaths/person years for each category of BMI: 0/0, 36/3402, 884/72 686, 3603/250 459, 3976/243 080, 1751/94 960, 1000/52 311, and 196/8275.

Additionally, excluded participants with lean body mass below 10th centile. For exclusion analyses, height adjusted lean body mass was used after regression out of variation due to height. No of deaths/person years for each category of BMI: 0/0, 7/781, 509/48 989, 3295/239 196, 3963/242 606, 1751/94 928, 1000/52 311, and 196/8275.

We further examined how the association of predicted fat mass and lean body mass with all cause mortality changed by different lag times (supplementary table E). With shorter lag times, predicted fat mass showed a less linear positive association with all cause mortality, whereas predicted lean body mass showed a stronger U shaped association with all cause mortality. We also examined the associations stratified by smoking status and age (supplementary tables F and G). The association between predicted fat mass and all cause mortality was stronger and more linear among never smokers than among current smokers and stronger among younger adults than among older adults. On the other hand, we observed a stronger U shaped association between predicted lean body mass and all cause mortality among current smokers than among never smokers or past smokers. We observed a similar U shaped association for predicted lean body mass across all age groups.

Our findings remained robust in several sensitivity analyses (supplementary tables H, I, and J). The results did not change with no adjustment for physical activity, exclusion of deaths early in the follow-up period and right censoring criteria for age, inclusion of baseline illness, or use of fifths and tenths for exposures. Moreover, use of other prediction equations with polynomial terms showed consistent results (data not shown but available on request).

Cause specific mortality
------------------------

We further examined the association of predicted fat mass and lean body mass with cause specific mortality ([table 4](#tbl4){ref-type="table"}). Mutually adjusted models showed a linear positive association between predicted fat mass and mortality from cardiovascular disease and cancer. Compared with those in the lowest fifth of predicted fat mass, men in the highest fifth had hazard ratios of 1.67 (1.47 to 1.89) for death from cardiovascular disease, 1.24 (1.09 to 1.43) for death from cancer, and 1.26 (0.97 to 1.64) for death from respiratory disease. In contrast, predicted lean body mass showed a U shaped association with mortality from cardiovascular disease and cancer in the mutually adjusted models. However, predicted lean body mass showed a strong inverse association with mortality from respiratory disease (P for trend \<0.001). Compared with those in the lowest fifth of predicted lean body mass, men in the highest fifth had a hazard ratio of 0.50 (0.39 to 0.65) for death from respiratory disease. When we examined the association between BMI and cause specific mortality, we observed a U shaped association for death from cardiovascular disease but a positive association for death from cancer and an inverse association for death from respiratory disease.

###### 

Hazard ratio (95% CI) of cause specific mortality according to predicted fat mass, lean body mass, and body mass index in men (Health Professionals Follow-up Study, 1987-2012)

  ------------------------------------------------------------------------------------------------------------------------------------------------------
  \                                                            Hazard ratio (95% CI)                                               
  ------------------------------------------------------------ ----------------------- --------------------- --------------------- ---------------------
  No of deaths                                                 4297                    3726                  960                   3373

  Incidence rate per 100 000 person years                      558                     483                   124                   437

  **Fifth of fat mass** [**\***](#t4n1){ref-type="table-fn"}                                                                       

  1 (lowest)                                                   1 (reference)           1 (reference)         1 (reference)         1 (reference)

  2                                                            1.11 (0.99 to 1.24)     1.15 (1.03 to 1.29)   0.92 (0.74 to 1.14)   1.01 (0.90 to 1.14)

  3                                                            1.10 (0.98 to 1.23)     1.06 (0.94 to 1.19)   1.06 (0.85 to 1.31)   0.84 (0.74 to 0.94)

  4                                                            1.30 (1.16 to 1.46)     1.15 (1.02 to 1.30)   1.10 (0.88 to 1.38)   1.02 (0.90 to 1.15)

  5 (highest)                                                  1.67 (1.47 to 1.89)     1.24 (1.09 to 1.43)   1.26 (0.97 to 1.64)   1.13 (0.98 to 1.30)

  P value for trend                                            \<0.001                 0.005                 0.03                  0.05

  **Lean body mass** [**\***](#t4n1){ref-type="table-fn"}                                                                          

  1 (lowest)                                                   1 (reference)           1 (reference)         1 (reference)         1 (reference)

  2                                                            0.96 (0.88 to 1.06)     0.97 (0.88 to 1.08)   0.61 (0.51 to 0.74)   0.94 (0.84 to 1.04)

  3                                                            0.95 (0.86 to 1.05)     0.94 (0.84 to 1.04)   0.58 (0.47 to 0.71)   0.95 (0.86 to 1.07)

  4                                                            0.96 (0.87 to 1.07)     0.95 (0.85 to 1.06)   0.57 (0.46 to 0.71)   1.00 (0.89 to 1.12)

  5 (highest)                                                  1.11 (0.99 to 1.24)     1.02 (0.90 to 1.16)   0.50 (0.39 to 0.65)   0.98 (0.86 to 1.12)

  P value for trend                                            0.10                    0.89                  \<0.001               0.99

  **Body mass index**                                                                                                              

  \<18.5                                                       1.45 (0.87 to 2.41)     0.66 (0.32 to 1.40)   5.33 (3.10 to 9.17)   1.86 (1.15 to 3.01)

  18.5-20.4                                                    1.12 (0.90 to 1.38)     0.99 (0.78 to 1.25)   1.93 (1.36 to 2.73)   0.92 (0.72 to 1.19)

  20.5-22.4                                                    0.95 (0.85 to 1.06)     0.97 (0.87 to 1.09)   1.30 (1.06 to 1.60)   1.09 (0.97 to 1.22)

  22.5-24.9                                                    1 (reference)           1 (reference)         1 (reference)         1 (reference)

  25.0-27.4                                                    1.16 (1.08 to 1.26)     1.01 (0.93 to 1.09)   0.91 (0.78 to 1.08)   0.96 (0.88 to 1.05)

  27.5-29.9                                                    1.40 (1.27 to 1.54)     1.13 (1.02 to 1.25)   1.09 (0.89 to 1.35)   1.10 (0.98 to 1.23)

  30.0-34.9                                                    1.75 (1.56 to 1.96)     1.12 (0.98 to 1.28)   0.81 (0.60 to 1.09)   1.18 (1.02 to 1.35)

  ≥35.0                                                        2.66 (2.11 to 3.36)     1.55 (1.17 to 2.04)   0.90 (0.43 to 1.92)   2.13 (1.63 to 2.77)

  P value for trend                                            \<0.001                 \<0.001               \<0.001               0.001
  ------------------------------------------------------------------------------------------------------------------------------------------------------

All models were adjusted for age, race (white or non-white), family history of cardiovascular disease (yes or no), family history of cancer (yes or no), physical activity (\<3, 3-8.9, 9-17.9, 18-26.9, or \>27 MET-h/week), alcohol consumption (0, 0.1-4.9, 5-9.9, 10-14.9, or ≥15 g/day), total energy intake (fifths), smoking status (never, ever, 1-14, 15-24, or ≥25 cigarettes/day), and Alternate Healthy Eating Index (fifths). Fat mass and lean body mass were mutually adjusted in model.

Derived from validated anthropometric prediction equations. Height was adjusted by inclusion as continuous variable for fat mass and by regression out of variation due to height for lean body mass.

Discussion
==========

In a large prospective cohort study of men, we used validated anthropometric prediction equations to examine the association of lean body mass and fat mass with all cause and cause specific mortality. We found a strong positive association between predicted fat mass and mortality from all causes, cardiovascular disease, and cancer. In contrast, predicted lean body mass showed a U shaped association with mortality from all causes, cardiovascular disease, and cancer, and an inverse association with mortality from respiratory disease.

Comparison with other studies
-----------------------------

Many epidemiologic studies have examined the relation between BMI and mortality, but confusion exists around the unexpected J shaped or U shaped association observed.[@ref8] [@ref9] A systematic review and meta-analysis of 97 prospective studies in 2013 reported that, relative to normal weight (BMI 18.5-24.9), obesity (BMI ≥30) was associated with higher all cause mortality, but overweight (BMI 25-29.9) was associated with lower all cause mortality.[@ref9] In contrast, a meta-analysis of data from individual participants in 239 prospective studies by the Global BMI Mortality Collaboration in 2016 found evidence that increased risk of all cause mortality among overweight people was largely due to confounding by smoking and reverse causation from underlying disease and frailty at older ages.[@ref8] Controversies are ongoing around the "obesity paradox,"[@ref40] [@ref41] [@ref42] with many studies still reporting excess mortality at the lower BMI range. More importantly, these studies acknowledged the major limitation of BMI as a measure of adiposity but did not directly investigate the two distinct compartments of body composition (lean body mass and fat mass) in relation to mortality.[@ref8] [@ref9]

Our findings on BMI were in line with the previous findings, whereby we consistently observed a J shaped association with mortality even after accounting for age, smoking, and baseline diseases. Our study added a new insight that the observed J shaped association between BMI and mortality can be explained when the two different shapes in mortality risk for fat mass and lean body mass are taken together. The increased risk of mortality in the lower BMI range (\<25) could be attributed to a combination of the high risk among men with low predicted lean body mass, which overrides the weak association between predicted fat mass and mortality in this lower range of BMI. The increase of mortality risk at the BMI range of 25-29.9 is likely due to the high risk associated with predicted fat mass in combination with only a moderate risk associated with predicted lean body mass. Lastly, the rapid increase in mortality risk in the higher BMI range (≥30) could be due to a very high risk associated with both predicted fat mass and lean body mass. Of note, at the high end of BMI (≥30), the vast majority of people have high predicted fat mass and lean body mass. Those with high predicted lean body mass almost invariably have high fat mass; for example, the average predicted fat mass for those in the highest tenth of predicted lean body mass was 31 kg (supplementary table J).

These observed patterns for fat mass and lean body mass were further supported by our additional analyses of BMI and mortality after exclusion of participants at the lower end of predicted lean body mass, which resulted in a strong linear positive relation between BMI and mortality. This shows that separating lean and healthy (low BMI and normal lean body mass) from lean and unhealthy (low BMI and low lean body mass) people could be a key to explain the obesity paradox phenomenon. One hypothesis states that accumulating excess fat may be causally beneficial for survivors of cancers or other diseases.[@ref43] However, our results suggest the possibility that people with more fat stores may seem to be at lower risk than those with lower BMI, but that this may not be causal but rather a result of the comparison group having low lean body mass.

To date, only a limited number of studies have examined mortality in relation to body composition measured directly using dual energy *x* ray absorptiometry or computed tomography.[@ref27] [@ref28] [@ref29] [@ref30] [@ref31] [@ref32] [@ref33] Most studies have been done in older populations with an approximate mean age of 75 years.[@ref27] [@ref28] [@ref29] [@ref31] [@ref33] The findings showed inconsistent and various shapes of the association. An Italian study of 934 older people showed no association of calf muscle and fat mass area with six year mortality,[@ref28] whereas another study of 2292 older people from the US found that low leg muscle area was associated with increased risk of six year mortality in men only.[@ref29] In contrast, other studies found that lower fat percentage or leg fat mass was associated with increased mortality,[@ref27] [@ref31] [@ref33] but only one of them, in 477 community dwelling older people from the Netherlands, reported that lower appendicular skeletal muscle mass was associated with increased risk of 12 year mortality.[@ref33] Although these studies used a direct measure of body composition, the study samples were restricted to an older population, which limits the generalizability of their findings. Moreover, they also had other limitations such as small sample size, short follow-up, exposure measured at one time point, lack of information on important confounders (especially smoking), and no examination of cause specific mortality. Nevertheless, our finding was consistent with a recent large scale Canadian study that measured dual energy *x* ray absorptiometry in participants referred for bone mineral density testing.[@ref30] That study found that high percentage fat and low BMI were independently associated with increased risk of mortality when percentage fat and BMI were simultaneously adjusted in the models. However, the observed associations might have been confounded by smoking or physical activity owing to a lack of information on those variables, and the study did not directly use lean body mass in the analysis.

The BMI-mortality association is prone to reverse causation by pre-existing diseases that can cause weight loss and also increase risk of mortality, and this is more likely to be a concern with shorter lag times. We found that, with shorter lag time periods, the positive association between predicted fat mass and mortality was attenuated, whereas the U shaped association between predicted lean body mass and mortality tended to be strengthened. Therefore, the stronger U shaped relation between BMI and mortality with shorter lag time periods can be mostly attributed to the pronounced U shaped association for predicted lean body mass, which may be an indicator of health status capturing any pre-existing undiagnosed medical condition, including frailty at older ages.

The influence of smoking is particularly important in investigating the obesity-mortality association. Not only is smoking a strong risk factor for death, but it also affects body weight and body composition.[@ref44] [@ref45] [@ref46] [@ref47] Similar to the BMI-mortality association, predicted fat mass showed a weaker and less linear association with mortality among current smokers than in past smokers or never smokers. Interestingly, we found a stronger U shaped association between predicted lean body mass and mortality among current smokers than in past or never smokers. Although we cannot completely rule out residual confounding by smoking, our findings showed some evidence that the frequently observed U shaped association between BMI and mortality among smokers may be affected by the strong U shaped association between lean body mass and mortality.

Strengths and limitations of study
----------------------------------

Our study has several strengths. Firstly, the innovative approach of validated anthropometric prediction equations allowed us to estimate lean body mass and fat mass practically in large epidemiologic settings. This is the first analysis to examine the association of predicted body composition with all cause and cause specific mortality in a large prospective cohort study. Secondly, the Health Professionals Follow-up Study is a well established prospective cohort study that has a large number of deaths over a long term follow-up period. Thirdly, detailed and updated information on lifestyle and health related factors allowed adequate control for confounding. Fourthly, repeated measures on exposures (that is, predicted scores) allowed prospective analyses of different lag time periods to examine reverse causality in the obesity-mortality association.

The study also has several limitations. Firstly, predicted lean body mass and fat mass are not perfect measures of actual lean body mass and fat mass. Nevertheless, the validation results from NHANES showed high predictive ability of the anthropometric equations with no systematic bias. In fact, the very high R^2^ between fat mass and lean body mass (\>0.90) for direct dual energy *x* ray absorptiometry measurements and predicted measures in an independent dataset indicate that a direct dual energy *x* ray absorptiometry measure would give very similar insights to ours; this is further supported by the equal predictive ability of the predicted measures and dual energy *x* ray absorptiometry measures for various obesity related biomarkers. Moreover, given the prospective study design, any mismeasurement in the exposures would likely be random with respect to endpoints, resulting in conservative associations. Secondly, we cannot entirely rule out the possibility of unmeasured or unknown confounding factors that may account for the associations observed in this study. However, the homogeneity of the study population and comprehensive data on the risk factors minimized potential confounding. Thirdly, the generalizability of the findings may be limited given that the study participants were restricted to health professionals and predominantly white men. However, we believe that our main findings will be broadly applicable.

Clinical and public health implications
---------------------------------------

This study provides strong evidence that excess fat mass increases the risk of mortality. Increased fat mass was not protective for mortality, which is counter to the premise of the "obesity paradox." On the other hand, low lean body mass was associated with an increased risk of mortality in the lower range of BMI. Our study suggests that understanding different contributions of lean body mass and fat mass to BMI may explain the shape of the association between BMI and mortality as well as the controversial matter of the obesity paradox. Our findings support recommendations to maintain a normal body weight defined by BMI of 18.5 to 24.9 for prevention of chronic diseases and further suggest that the lowest mortality risk can be observed at the lower normal range of BMI if the influence of lean body mass on mortality is accounted for. The recommendations should highlight not only the importance of normal body weight but also healthy body composition (for example, healthy lean) to reduce confusion around the optimal weight (the obesity paradox) for overall health. Interventions and strategies to promote healthy body composition through lifestyle modification (such as physical activity and diet) may be an important next step to improve the health of the population.

Conclusions
-----------

We found a strong positive association between predicted fat mass and mortality and a U shaped association between predicted lean body mass and mortality in men. Low lean body mass, rather than low fat mass, may be driving the increased risk of mortality in the lower BMI range. Understanding the independent roles of lean body mass and fat mass has important implications for clarifying the obesity paradox phenomenon in the association between BMI and mortality.

### What is already known on this topic

1.  Many epidemiologic studies have shown an unexpected J shaped or U shaped relation between body mass index (BMI) and mortality ("obesity paradox")

2.  The controversial obesity paradox phenomenon may have arisen in part owing to underappreciation of different contributions of lean body mass and fat mass to BMI

3.  Direct measurement of body composition is difficult in large epidemiologic settings, so the relation between body composition and mortality is still unknown

### What this study adds

1.  This study represents the first effort to comprehensively examine the association between lean body mass, fat mass, and mortality in a large prospective cohort study

2.  Predicted fat mass showed a strong positive monotonic association with mortality, whereas predicted lean body mass showed a strong U shaped association with mortality

3.  The obesity paradox controversy may be largely explained by low lean body mass, rather than low fat mass, in the lower range of BMI
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